ACCESS4ME

Serial Number 97399084
Registration 7328701
700

Registration Progress

Application Filed
May 6, 2022
Under Examination
Mar 14, 2023
Approved for Publication
Jan 17, 2023
Published for Opposition
Jan 17, 2023
Registered
Mar 12, 2024

Trademark Image

ACCESS4ME

Basic Information

Serial Number
97399084
Registration Number
7328701
Filing Date
May 6, 2022
Registration Date
March 12, 2024
Published for Opposition
January 17, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Mar 12, 2024
Registration
Registered
Classes
035 036 044

Rights Holder

Spectrum Pharmaceuticals, Inc.

03
Address
18200 Von Karman Ave
Irvine, CA 92618

Ownership History

Spectrum Pharmaceuticals, Inc.

Original Applicant
03
Irvine, CA

Spectrum Pharmaceuticals, Inc.

Owner at Publication
03
Irvine, CA

Spectrum Pharmaceuticals, Inc.

Original Registrant
03
Irvine, CA

Legal Representation

Attorney
Tim Burgdorf

USPTO Deadlines

Next Deadline
1517 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20240312)
Due Date
March 12, 2030
Grace Period Ends
September 12, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

38 events
Date Code Type Description Documents
Mar 12, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Mar 12, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Feb 9, 2024 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Feb 8, 2024 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Feb 7, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 7, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 7, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 17, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jan 17, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jan 17, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Dec 1, 2023 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Dec 1, 2023 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Sep 3, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 3, 2023 GNRT O NON-FINAL ACTION E-MAILED Loading...
Sep 3, 2023 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Aug 24, 2023 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Aug 15, 2023 IUAF S USE AMENDMENT FILED Loading...
Aug 24, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Aug 15, 2023 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Aug 9, 2023 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Mar 14, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 17, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 17, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 28, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 13, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 13, 2022 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Dec 13, 2022 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Dec 13, 2022 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Dec 13, 2022 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Dec 12, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 12, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 12, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 15, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jul 15, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jul 15, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 8, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
May 12, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 10, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 035
Referral services in the field of treatment for cancer, chemotherapy and pharmaceutical products in the nature of business administrative services for medical referrals; business administration of prescription drug co-payment programs; business administration of patient reimbursement programs; referral services in the field of co-pay assistance programs in the nature of providing insurance agent referrals; providing an online commercial information directory in the field of patient support featuring information regarding healthcare providers, sites at which subcutaneous injections could be administered and retail pharmacies or specialty pharmacies where patients could obtain pharmaceutical preparations
First Use Anywhere: Sep 16, 2022
First Use in Commerce: 20221100
Class 036
Providing healthcare administration, namely, providing insurance verification and prior authorization services in the nature of insurance eligibility review, verification and consultation for others
First Use Anywhere: Sep 16, 2022
First Use in Commerce: 20221000
Class 044
Patient support services relating to the treatment of medical disorders, namely, providing online information in the field of the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations for treatment of various diseases and providing medical consultancy and advisory services via a global computer network; providing health and medical information about medical disorders; information services, namely, providing medical information to cancer patients; providing patient support services relating to cancer and cancer treatment in the nature of an Internet based database of patient medical information where patients can inquire about medical issues and procedures from other patients and can relay information about their medical experiences for support and community; providing a website featuring medical and health information; providing a website featuring information in the field of the prophylactic and therapeutic properties of pharmaceuticals; providing medical information and information in the field of the prophylactic and therapeutic properties of pharmaceuticals; providing health information; providing patients with online medical information; providing health information, namely, providing cancer diagnosis and treatment data on the genetics and genetic sequencing of cancer tumors and cells
First Use Anywhere: Sep 16, 2022
First Use in Commerce: 20221000

Additional Information

Pseudo Mark
ACCESS 4 ME; ACCESS FOUR ME; ACCESS FOR ME

Classification

International Classes
035 036 044